At a glance
ClinicalIndex Comparison RecordN/ACompleted· 26 enrolled
Drug / intervention
Maltodextrin +2 moredietary
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Revealing the Mechanisms by Which Milk Sugars Exaggerate Postprandial Lipaemia
In Brief
A clinical study evaluating Maltodextrin, Sucrose, and 1 other intervention for Cardiovascular Risk Factor and 2 related conditions. Completed, enrolled 26 participants across 1 site.
Detailed Summary
This study aims to determine to what extent ingestion of free sugars influence postprandial triglyceridaemia in men and women.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCardiovascular Risk Factor, Lipaemia, Metabolic Disease
CountriesUnited Kingdom
CollaboratorsUniversity of Oxford, British Heart Foundation
Timeline
N/ACompletedFinished
20222023202420252026
Enrollment StartJun 2021
First PostedJun 2021
Primary CompletionJul 2022
Study CompletionJul 2023
TodayJul 2026
First PostedJun 14, 2021
Enrollment StartJun 7, 2021
Primary CompletionJul 13, 2022
Study CompletionJul 21, 2023
TodayJul 2, 2026
Enrollment to primary: 1.1 yearsPosted 5.0 years ago
Interventions
Maltodextrindietary
Co-ingestion of maltodextrin with a high fat meal
Sucrosedietary
Co-ingestion of sucrose with a high fat meal
Lactosedietary
Co-ingestion of lactose with a high fat meal